Press Release Apr 10 2023
Filed with NSE · · 2 pages · English
Summary by 6ix AI
The approval allows Zydus to manufacture and market the drug, which treats various bacterial infections. The tablets will be produced at the company's facility in Moraiya, Ahmedabad.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Apr 06 2023
- Press Release Mar 28 2023
- Press Release Mar 25 2023
- Press Release Mar 24 2023
- Press Release Mar 21 2023
Later from Zydus Lifesciences
- Press Release Apr 11 2023
- Press Release Apr 15 2023
- Press Release Apr 18 2023
- Press Release Apr 19 2023
- Press Release Apr 20 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences